DDX53 and neoplasm: CT26/GM-CSF, CT26/IL18, and CT26/GM-CSF/IL-18 cells (1 ×106 of each) were inoculated subcutaneously into Balb/C mice, and tumor volume was monitored from tumor-bearing mice every 3 or 4 days.